Vanguard Personalized Indexing Management’s Cabaletta Bio CABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.8K Sell
10,853
-8,537
-44% -$28.1K ﹤0.01% 2174
2026
Q1
$52.2K Sell
19,390
-2,994
-13% -$8.31K ﹤0.01% 2045
2025
Q4
$49K Buy
22,384
+233
+1% +$577 ﹤0.01% 1885
2025
Q3
$51.8K Sell
22,151
-2,797
-11% -$4.8K ﹤0.01% 1898
2025
Q2
$37.9K Buy
24,948
+5,569
+29% +$8.69K ﹤0.01% 1856
2025
Q1
$26.8K Buy
19,379
+966
+5% +$2.06K ﹤0.01% 1743
2024
Q4
$41.8K Buy
18,413
+8,240
+81% +$28.9K ﹤0.01% 1714
2024
Q3
$48K Buy
+10,173
New +$58.9K ﹤0.01% 1680

Other funds holding CABA

Vanguard Personalized Indexing Management's CABA Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Cabaletta Bio (CABA) stake by 44% in Q2 2026, selling an estimated $28.1K and leaving 10,853 shares worth $33.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2174.

Vanguard Personalized Indexing Management first reported a position in CABA in Q3 2024 and has held it in 8 quarters since. The position peaked at $52.2K in Q1 2026. 86 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Vanguard Personalized Indexing Management held 10,853 shares of Cabaletta Bio worth $33.8K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 8,537 Cabaletta Bio shares in Q2 2026, an estimated $28.1K.
  • Cabaletta Bio made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2174 holding.
  • Vanguard Personalized Indexing Management first reported a position in Cabaletta Bio in Q3 2024 and has held it in 8 quarters since.
  • Vanguard Personalized Indexing Management's Cabaletta Bio position peaked at $52.2K in Q1 2026.
  • 86 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.